Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe Recalled by MRP, LLC dba Aquabiliti Due to The saline flush syringes may fail to meet...

Date: December 28, 2023
Company: MRP, LLC dba Aquabiliti
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact MRP, LLC dba Aquabiliti directly.

Affected Products

AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REF 2T0807, intermediate cartons containing 100 syringes, shipping cases containing 400 syringes, Rx, Sterile.

Quantity: 3,080,000 syringes

Why Was This Recalled?

The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About MRP, LLC dba Aquabiliti

MRP, LLC dba Aquabiliti has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report